J2 Global, Inc. recently announced that its subsidiary, Ziff Davis LLC, has completed the acquisition of Everyday Health, Inc. The company had earlier made a tender offer to purchase outstanding shares of Everyday Health for $10.50 each. After its successful completion, the remaining shares not tendered and not owned by Ziff Davis procured right to be converted to receive $10.50 in cash. The conversions were carried out as per regulations. Following the deal completion, Everyday Health has become a wholly owned subsidiary of Ziff Davis.
Deal Benefits
The integration from the deal is expected to create synergies in the future. Both companies have a strong business model and are well known in their respective fields in the digital media industry. Ziff Davis is popular in the technology, gaming and men's lifestyle genre with well-known brands. Everyday Health, on the other hand, provides trusted digital health marketing and communication solutions. The deal expands the current audience base for both companies who together reached more than 86 million persons in September, according to comScore. Collectively, the companies generated $522 million in revenues over the last 12 months. Some of the leading brands under the now combined portfolio include Everyday Health, WhatToExpect, IGN, PCMag and Speedtest.
Zacks Rank
j2Global carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
We note that the stock has been performing well over the past few months and has comfortably outperformed the Zacks categorized Internet Software Market over the last three months. The stock has gained over 11.94% compared with the industry, which has declined 7.13% over the same period.
The company continues to put in efforts to boost its performance despite increasing competition from peers like Nice Ltd.(NICE - Free Report) , Atlassian Corporation Plc (TEAM - Free Report) , and Box, Inc. (BOX - Free Report) .
Zacks’ Best Private Investment Ideas
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time?
Ourexperts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
J2 Global, Inc. recently announced that its subsidiary, Ziff Davis LLC, has completed the acquisition of Everyday Health, Inc. The company had earlier made a tender offer to purchase outstanding shares of Everyday Health for $10.50 each. After its successful completion, the remaining shares not tendered and not owned by Ziff Davis procured right to be converted to receive $10.50 in cash. The conversions were carried out as per regulations. Following the deal completion, Everyday Health has become a wholly owned subsidiary of Ziff Davis.
Deal Benefits
The integration from the deal is expected to create synergies in the future. Both companies have a strong business model and are well known in their respective fields in the digital media industry. Ziff Davis is popular in the technology, gaming and men's lifestyle genre with well-known brands. Everyday Health, on the other hand, provides trusted digital health marketing and communication solutions. The deal expands the current audience base for both companies who together reached more than 86 million persons in September, according to comScore. Collectively, the companies generated $522 million in revenues over the last 12 months. Some of the leading brands under the now combined portfolio include Everyday Health, WhatToExpect, IGN, PCMag and Speedtest.
Zacks Rank
j2Global carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
We note that the stock has been performing well over the past few months and has comfortably outperformed the Zacks categorized Internet Software Market over the last three months. The stock has gained over 11.94% compared with the industry, which has declined 7.13% over the same period.
The company continues to put in efforts to boost its performance despite increasing competition from peers like Nice Ltd.(NICE - Free Report) , Atlassian Corporation Plc (TEAM - Free Report) , and Box, Inc. (BOX - Free Report) .
Zacks’ Best Private Investment Ideas
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time?
Ourexperts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on NICE - FREE
Get the latest research report on BOX - FREE
Get the latest research report on TEAM - FREE